PXD068810 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Plasma Exosomal Proteomics: Unveiling Novel Biomarkers for Ischemic Stroke in the Context of Diabetes |
| Description | Diabetes increases the risk of ischemic stroke and mortality. Exosomes, which are vesicles abundant of not only nucleic acids but also proteins, transmit stable cellular information and traverse the blood-brain barrier, emerge as promising biomarkers for brain injury and non-invasive monitoring. Investigating exosome-proteomics might unveil innovative therapeutic strategies for improving outcomes in diabetic stroke patients. Exosomes were isolated from the plasma of acute ischemic stroke patients with and without type 2 diabetes (n=10 each). Electron microscopy and flow cytometry were employed to analyze exosome morphology and markers, while nanoparticle tracking assessed concentration and size. Label-free quantitative proteomics and bioinformatics identified novel prognostic biomarkers. The CIBERSORTx and BRETIGEA tools were respectively used to elucidate immune and brain cell-specific protein expression patterns from exosomes. Diabetic stroke patients exhibited elevated fasting glucose, HbA1c, and neutrophil levels. Proteomic profiling revealed 95 differentially expressed proteins (21 up-regulated, 74 down-regulated). Functional enrichment analyses (GO and KEGG) associated diabetic stroke with disrupted oxygen/nitric oxide transport, cellular and glucose metabolism, and reactive oxygen species response. Protein-protein interaction network analysis highlighted the recombinant hemoglobin family (HBA1, HBA2, HBB), human β defensin (HBD), phosphofructokinase-1 liver type (PFKL), and aldehyde dehydrogenase 3 family member A2 (ALDH3A2) as key regulators. Diabetes altered exosomal contributions, diminishing signals from CD4 memory T cells and brain endothelial cells, while enhancing those from follicular helper T cells. These findings underscore the potential of exosome-based diagnostics and therapeutics for diabetic stroke, paving the way for innovative therapeutic strategies. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-04-13 |
| AnnouncementXML | Submission_2026-04-12_17:03:20.227.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Haiping Zhao |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | carboxylated residue |
| Instrument | ultraflex |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-09-24 21:19:41 | ID requested | |
| ⏵ 1 | 2026-04-12 17:03:21 | announced | |
Publication List
| 10.1016/j.brainresbull.2026.111884; |
| Jiang Q, Peng G, Kong Q, Zhou Y, Zhao H, Geng X, Plasma exosomal proteomics: Unveiling novel biomarkers for ischemic stroke in the context of diabetes. Brain Res Bull, 239():111884(2026) [pubmed] |
Keyword List
| submitter keyword: Diabetes;Exosomes;Proteomics |
Contact List
| Haiping Zhao |
| contact affiliation | Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University, Beijing, China |
| contact email | zhaohaiping1980@163.com |
| lab head | |
| Haiping Zhao |
| contact affiliation | Institute of Cerebrovascular Diseases Research, Xuanwu Hospital of Capital Medical University |
| contact email | zhaohaiping1980@163.com |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/04/PXD068810 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD068810
- Label: PRIDE project
- Name: Plasma Exosomal Proteomics: Unveiling Novel Biomarkers for Ischemic Stroke in the Context of Diabetes